DETERMINANTS OF DISEASE AND DISABILITY IN THE ELDERLY - THE ROTTERDAM ELDERLY STUDY

被引：993

作者：

HOFMAN, A

GROBBEE, DE

DEJONG, PTVM

VANDENOUWELAND, FA

机构：

[1] Department of Epidemiology and Biostatistics and Department of Ophthalmology, Erasmus University Medical School, DR Rotterdam, 3000

来源：

EUROPEAN JOURNAL OF EPIDEMIOLOGY | 1991年 / 7卷 / 04期

关键词：

AGING; COHORT STUDY; DETERMINANTS; DISEASE; EPIDEMIOLOGY; FOLLOW-UP STUDY;

D O I：

10.1007/BF00145007

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

In this paper the Rotterdam Elderly Study is presented. The aim of the study is to investigate determinants of disease occurrence and progression in the elderly. In addition to contributing to our understanding of the etiology of geriatric illnesses, the study is expected to lead to specific recommendations for intervention. The study focusses on causally related determinants of major diseases in the elderly. Fields of interest for the Rotterdam Elderly Study are conditions which interfere the most with the quality of life for the elderly. The aims of the Rotterdam Elderly Study are: (1) To investigate, by means of epidemiologic, clinical and basic research, the determinants of diseases in order to assess their etiologic significance. (2) To investigate potentially modifiable determinants in order to be able to develop preventive strategies by providing specific recommendations for intervention studies. The Rotterdam Elderly Study focusses on four primary areas of research: neurogeriatric diseases, cardiovascular diseases, locomotor diseases and ophthalmologic diseases. It is a prospective follow-up study, in which determinants of disease and determinants of progression of disease will be investigated in the total population of 55 years or over of the district of Ommoord in Rotterdam. It is anticipated that about 10,000 people will participate in the study and they will be examined in the period of 1991 to 1995.

引用

页码：403 / 422

页数：20

共 95 条

[81] Stahelin H.B., Senile dementia in relation to nutritional factors, Bibl Nutr Dieta, 38, pp. 136-44, (1986)
[82] Stolk R.P., Grobbee D.E., Insulin and ischemic cardiovascular disease, J Drug Res, 15, pp. 165-9, (1990)
[83] Stout R.W., Crawford V., Active life expectancy and terminal dependency: Trends in long-term geriatric care over 33 years, Lancet, 1, pp. 281-3, (1988)
[84] Strasser T., Cardiovascular care of the elderly, (1985)
[85] Sulkava R., Erliunjuntti T., Palo J., Head injury in Alzheimer's disease and vascular dementia, Neurology, 35, pp. 1530-1, (1985)
[86] Final report on the aspirin component of the ongoing Physicians' Health Study, N Engl J Med, 321, pp. 129-35, (1989)
[87] The Atherosclerosis Risk in Communities (ARIL) Study: Design and Objectives, Am J Epidemiology, 129, pp. 687-702, (1989)
[88] Thompson S.G., Duckert F., Haverkate F., Et al., The Measurement of Haemostasis factors in 16 European Laboratories: Quality Thrombosis and Haemostasis, 61, pp. 301-306, (1989)
[89] Trouerbach, Hoornstra K., Birkenhager J.C., Zwamborn A.W., Röntgendensitometric study of the phalanx, Diagn Im Clin Med, 54, pp. 64-77, (1985)
[90] van Vroonhoven T., Screening for abdominal aortic anuerysms, Ned Tijdschr Geneeskd, 133, pp. 1061-2, (1989)

← 1 2 3 4 5 6 7 8 9 10 →